Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.3 is now displayed, indicating a small software version update to the site's interface. This change does not affect study details or other user-facing information.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a newer version of the study documents on ClinicalTrials.gov.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment status updated to indicate no longer looking for participants, signaling that enrollment has completed. Added navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and minor formatting changes to the Intervention/Treatment label, along with a revision tag update from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page's revision label was updated to Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a new build/version deployment for the study details page.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision stamp updated from v3.5.3 to v3.5.4, representing a new release version of the site. The change does not modify visible content or study information on the page.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision label was updated to v3.5.3, replacing the previous v3.5.2, indicating a backend build update with no changes to study information.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.